Details for Patent: 11,191,908

Which drugs does patent 11,191,908 protect, and when does it expire?

Patent 11,191,908 protects XYOSTED (AUTOINJECTOR) and is included in one NDA.

This patent has eleven patent family members in five countries.

Summary for Patent: 11,191,908

Title:	Syringe shock absorber for use in an injection device
Abstract:	An injection device, for example, an auto-injector of any type, includes a sleeve configured to hold a medicament chamber. The sleeve may be sufficiently deformable such that it functions as a shock absorbing member to distribute the force exerted on the medicament chamber during use of the injection device.
Inventor(s):	Mehawej; John Pierre (Robbinsdale, MN), Travanty; Michael (Wayzata, MN)
Assignee:	Antares Pharma, Inc. (Ewing, NJ)
Application Number:	15/503,077
Patent Claim Types: see list of patent claims	Dosage form;

Drugs Protected by US Patent 11,191,908

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Antares Pharma Inc	XYOSTED (AUTOINJECTOR)	testosterone enanthate	SOLUTION;SUBCUTANEOUS	209863-001	Sep 28, 2018		RX	Yes	Yes			Y
Antares Pharma Inc	XYOSTED (AUTOINJECTOR)	testosterone enanthate	SOLUTION;SUBCUTANEOUS	209863-002	Sep 28, 2018		RX	Yes	Yes			Y
Antares Pharma Inc	XYOSTED (AUTOINJECTOR)	testosterone enanthate	SOLUTION;SUBCUTANEOUS	209863-003	Sep 28, 2018		RX	Yes	Yes			Y

Foreign Priority and PCT Information for Patent: 11,191,908

PCT Information
PCT Filed	August 07, 2015	PCT Application Number:	PCT/US2015/044271
PCT Publication Date:	February 18, 2016	PCT Publication Number:	WO2016/025327

International Family Members for US Patent 11,191,908

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Canada	2957679
European Patent Office	3177346
European Patent Office	3984572
Spain	2886553
Japan	2017523858
Japan	2019150661